Cannabinoid modulation of limbic forebrain noradrenergic circuitry

Both the endocannabinoid and noradrenergic systems have been implicated in neuropsychiatric disorders. Importantly, low levels of norepinephrine are seen in patients with depression, and antagonism of the cannabinoid receptor type 1 (CB1R) is able to induce depressive symptoms in rodents and humans....

ver descrição completa

Detalhes bibliográficos
Autor principal: Carvalho, Ana Raquel Franky Gomes (author)
Outros Autores: Mackie, Kenneth (author), Van Bockstaele, Elisabeth J. (author)
Formato: article
Idioma:eng
Publicado em: 2010
Assuntos:
Texto completo:http://hdl.handle.net/1822/67527
País:Portugal
Oai:oai:repositorium.sdum.uminho.pt:1822/67527